Skip to main content

Experimental Therapy Eases Alzheimer's Signs, Symptoms in Mice

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 29, 2023.

By Carole Tanzer Miller HealthDay Reporter

FRIDAY, Dec. 29, 2023 -- A new cellular therapy improved learning and memory in mice with Alzheimer's disease, researchers report.

The therapy -- developed at the University of Nebraska Medical Center (UNMC) -- relies on both the immune system to fight key aspects of Alzheimer's, plus modified cells that zero in on the brain protein plaques that are a hallmark of the disease.

In patients with Alzheimer's, amyloid-beta protein forms plaques that prevent nerve cells from signaling each other. One theory is that this might cause irreversible memory loss and behavior changes characteristic of Alzheimer's disease.

The new study was recently published in the journal Molecular Neurodegeneration. Researchers used genetically modified immune-controlling cells called Tregs to target amyloid-beta.

When the UNMC team injected the modified Treg cells into the bloodstreams of mice, buildup of plaque and brain inflammation slowed. Thinking skills also appeared to improve in the diseased mice.

While the results of animal studies often turn out differently in humans, researchers were encouraged by the findings.

"The study is an important development in the field that advances the possibility of using cell-based therapies for targeting protein aggregates in neurodegenerative diseases," said senior investigator Dr. Avindra Nath, of the National Institutes of Health, which funded the study.

Researchers said the engineered immune cells could offer a targeted and more effective treatment for Alzheimer's, a disease affecting an estimated 6.7 million Americans.

Lead study author Pravin Yeapuri, a postdoctoral fellow at UNMC, noted that other recent clinical trials have also shown the benefit of using Treg cells in treating Alzheimer's and other degenerative brain diseases.

"But the limitation has been how to get protective cells into the regions of the brain most affected in Alzheimer's disease," he explained in a UNMC news release.

The next step will be testing this approach in humans. Those close to the study are optimistic.

"We look forward with great excitement to seeing where this important breakthrough may lead in the fight against Alzheimer's," said UNMC chancellor Dr. Jeffrey Gold.

Sources

  • University of Nebraska Medical Center, news release, Dec. 27, 2023

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted December 2023

Read this next

Animal Studies Suggest New Treatment Target for Spinal Cord Injury

FRIDAY, June 14, 2024 -- Spinal cord injuries can cause the body to go haywire, with misfiring nerves causing dangerous “fight-or-flight” responses. This makes...

Could Moms of Low-Birth-Weight Babies Face Higher Dementia Risk Later?

THURSDAY, June 13, 2024 -- Women who deliver low-birth-weight babies could be more likely to have memory and thinking problems later in life, a new study warns. As seniors, these...

9/11 Responders May Face Higher Odds for Dementia

WEDNESDAY, June 12, 2024 -- After helping America through one of its worst tragedies, some responders to the events of 9/11 may now face another foe: Heightened risks for...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.